Gene Symbol | Gene ID | Gene Info |
---|---|---|
Bsx
|
ENSMUSG00000054360.3 | brain specific homeobox |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr9_40877257_40878943 | Bsx | 3973 | 0.159764 | -0.30 | 1.8e-02 | Click! |
chr9_40858564_40859594 | Bsx | 15048 | 0.113473 | 0.29 | 2.7e-02 | Click! |
chr9_40873932_40874434 | Bsx | 56 | 0.962756 | -0.25 | 5.9e-02 | Click! |
chr9_40879133_40879419 | Bsx | 5149 | 0.147486 | -0.24 | 7.0e-02 | Click! |
chr9_40876629_40876841 | Bsx | 2608 | 0.196935 | -0.22 | 9.5e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr18_25749825_25750329 | 5.88 |
Celf4 |
CUGBP, Elav-like family member 4 |
2615 |
0.33 |
chr17_90452868_90453681 | 4.57 |
Nrxn1 |
neurexin I |
1548 |
0.36 |
chr14_98164357_98165375 | 3.95 |
Dach1 |
dachshund family transcription factor 1 |
4677 |
0.28 |
chr1_115684558_115685809 | 3.92 |
Cntnap5a |
contactin associated protein-like 5A |
427 |
0.58 |
chr14_75963198_75963625 | 3.69 |
Kctd4 |
potassium channel tetramerisation domain containing 4 |
8402 |
0.18 |
chr16_43504464_43505047 | 3.52 |
Zbtb20 |
zinc finger and BTB domain containing 20 |
1058 |
0.61 |
chr2_113828248_113829427 | 3.42 |
Scg5 |
secretogranin V |
75 |
0.97 |
chr6_55680133_55680881 | 3.22 |
Neurod6 |
neurogenic differentiation 6 |
756 |
0.69 |
chrX_166348094_166348432 | 3.22 |
Gpm6b |
glycoprotein m6b |
3421 |
0.29 |
chrX_110811626_110812334 | 3.19 |
Gm44593 |
predicted gene 44593 |
344 |
0.89 |
chr8_67817715_67818694 | 3.03 |
Psd3 |
pleckstrin and Sec7 domain containing 3 |
29 |
0.99 |
chrX_166346283_166346827 | 2.98 |
Gpm6b |
glycoprotein m6b |
1713 |
0.43 |
chr4_110285468_110287125 | 2.95 |
Elavl4 |
ELAV like RNA binding protein 4 |
320 |
0.94 |
chr4_5724213_5725550 | 2.92 |
Fam110b |
family with sequence similarity 110, member B |
569 |
0.81 |
chr3_158559356_158560580 | 2.92 |
Lrrc7 |
leucine rich repeat containing 7 |
1368 |
0.57 |
chr12_89815214_89815490 | 2.85 |
Nrxn3 |
neurexin III |
2869 |
0.41 |
chr4_116404856_116405098 | 2.84 |
Mast2 |
microtubule associated serine/threonine kinase 2 |
1009 |
0.55 |
chr14_39469812_39470401 | 2.76 |
Nrg3 |
neuregulin 3 |
2560 |
0.44 |
chrX_103184543_103184694 | 2.64 |
Nap1l2 |
nucleosome assembly protein 1-like 2 |
2022 |
0.23 |
chr16_81201314_81201888 | 2.63 |
Ncam2 |
neural cell adhesion molecule 2 |
844 |
0.72 |
chr13_83732205_83734272 | 2.62 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
672 |
0.58 |
chr19_38348426_38349048 | 2.59 |
Gm50150 |
predicted gene, 50150 |
6123 |
0.16 |
chrX_58033180_58034063 | 2.59 |
Zic3 |
zinc finger protein of the cerebellum 3 |
2611 |
0.36 |
chr2_6873585_6874006 | 2.58 |
Celf2 |
CUGBP, Elav-like family member 2 |
1198 |
0.49 |
chr8_34888384_34889150 | 2.57 |
Tnks |
tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase |
1384 |
0.49 |
chr18_23036665_23037864 | 2.57 |
Nol4 |
nucleolar protein 4 |
1392 |
0.59 |
chr1_146494200_146495557 | 2.54 |
Gm29514 |
predicted gene 29514 |
73 |
0.56 |
chr10_109008310_109009456 | 2.54 |
Syt1 |
synaptotagmin I |
217 |
0.96 |
chr7_27653599_27654745 | 2.52 |
Ttc9b |
tetratricopeptide repeat domain 9B |
257 |
0.83 |
chr14_108909489_108909909 | 2.50 |
Slitrk1 |
SLIT and NTRK-like family, member 1 |
4459 |
0.37 |
chr14_66865047_66865736 | 2.48 |
Dpysl2 |
dihydropyrimidinase-like 2 |
3297 |
0.19 |
chr1_78195176_78196209 | 2.45 |
Pax3 |
paired box 3 |
1146 |
0.55 |
chr10_90577565_90578158 | 2.45 |
Anks1b |
ankyrin repeat and sterile alpha motif domain containing 1B |
869 |
0.72 |
chr9_41585694_41587243 | 2.43 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
1301 |
0.29 |
chr16_78313182_78314564 | 2.40 |
Cxadr |
coxsackie virus and adenovirus receptor |
11334 |
0.15 |
chr5_19907724_19909563 | 2.39 |
Magi2 |
membrane associated guanylate kinase, WW and PDZ domain containing 2 |
682 |
0.82 |
chr3_5225104_5225624 | 2.38 |
Zfhx4 |
zinc finger homeodomain 4 |
3859 |
0.22 |
chr3_34561815_34562105 | 2.38 |
Sox2ot |
SOX2 overlapping transcript (non-protein coding) |
1568 |
0.33 |
chr4_115133068_115134495 | 2.37 |
Cyp4x1os |
cytochrome P450, family 4, subfamily x, polypeptide 1, opposite strand |
51 |
0.69 |
chr2_65620767_65621991 | 2.36 |
Scn2a |
sodium channel, voltage-gated, type II, alpha |
568 |
0.82 |
chr9_41579198_41579349 | 2.35 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
221 |
0.86 |
chr1_194621653_194621902 | 2.34 |
Plxna2 |
plexin A2 |
1952 |
0.34 |
chr5_20228356_20229007 | 2.34 |
Magi2 |
membrane associated guanylate kinase, WW and PDZ domain containing 2 |
495 |
0.83 |
chr3_68572046_68573169 | 2.33 |
Schip1 |
schwannomin interacting protein 1 |
362 |
0.89 |
chr10_18410119_18410270 | 2.32 |
Nhsl1 |
NHS-like 1 |
2519 |
0.35 |
chr13_104914221_104914837 | 2.28 |
Gm4938 |
predicted pseudogene 4938 |
4251 |
0.27 |
chr1_9296734_9297036 | 2.26 |
Sntg1 |
syntrophin, gamma 1 |
1351 |
0.42 |
chr4_134467038_134467189 | 2.24 |
Stmn1 |
stathmin 1 |
1207 |
0.26 |
chr4_78209143_78209724 | 2.19 |
Ptprd |
protein tyrosine phosphatase, receptor type, D |
2306 |
0.29 |
chr2_65565600_65566271 | 2.19 |
Scn3a |
sodium channel, voltage-gated, type III, alpha |
1557 |
0.45 |
chr2_7395418_7396363 | 2.18 |
Celf2 |
CUGBP, Elav-like family member 2 |
3 |
0.99 |
chr8_41054476_41055299 | 2.18 |
Mtus1 |
mitochondrial tumor suppressor 1 |
93 |
0.95 |
chr7_128690432_128691249 | 2.18 |
Gm16044 |
predicted gene 16044 |
1849 |
0.17 |
chr17_17402413_17403374 | 2.16 |
Lix1 |
limb and CNS expressed 1 |
221 |
0.91 |
chr14_75964008_75964248 | 2.14 |
Gm25517 |
predicted gene, 25517 |
8491 |
0.18 |
chrX_147552057_147552289 | 2.13 |
Lrch2 |
leucine-rich repeats and calponin homology (CH) domain containing 2 |
1877 |
0.42 |
chr12_117153278_117156362 | 2.10 |
Gm10421 |
predicted gene 10421 |
3169 |
0.37 |
chr17_51760240_51761547 | 2.10 |
C230085N15Rik |
RIKEN cDNA C230085N15 gene |
728 |
0.54 |
chr11_108607202_108607707 | 2.09 |
Cep112 |
centrosomal protein 112 |
2227 |
0.37 |
chr8_34811262_34812206 | 2.05 |
Dusp4 |
dual specificity phosphatase 4 |
4437 |
0.25 |
chrX_49272929_49273965 | 2.05 |
Enox2 |
ecto-NOX disulfide-thiol exchanger 2 |
14765 |
0.24 |
chr15_8708421_8709156 | 2.03 |
Slc1a3 |
solute carrier family 1 (glial high affinity glutamate transporter), member 3 |
800 |
0.71 |
chr15_25411393_25411893 | 2.03 |
Basp1 |
brain abundant, membrane attached signal protein 1 |
2055 |
0.24 |
chr10_123266644_123266795 | 2.02 |
Tafa2 |
TAFA chemokine like family member 2 |
1734 |
0.4 |
chr14_108910678_108911967 | 2.01 |
Slitrk1 |
SLIT and NTRK-like family, member 1 |
2836 |
0.42 |
chr7_54837919_54838485 | 1.96 |
Luzp2 |
leucine zipper protein 2 |
2587 |
0.31 |
chr18_84082718_84083733 | 1.96 |
Tshz1 |
teashirt zinc finger family member 1 |
1850 |
0.29 |
chr16_67618113_67618498 | 1.96 |
Cadm2 |
cell adhesion molecule 2 |
2188 |
0.39 |
chr3_148984296_148985724 | 1.94 |
Gm43573 |
predicted gene 43573 |
4142 |
0.2 |
chr5_130448513_130449808 | 1.92 |
Caln1 |
calneuron 1 |
359 |
0.91 |
chr1_6733530_6734383 | 1.92 |
St18 |
suppression of tumorigenicity 18 |
914 |
0.7 |
chr3_127225406_127226570 | 1.91 |
Ank2 |
ankyrin 2, brain |
55 |
0.97 |
chr12_24829454_24829782 | 1.91 |
Mboat2 |
membrane bound O-acyltransferase domain containing 2 |
1261 |
0.32 |
chr5_98184068_98184753 | 1.90 |
A730035I17Rik |
RIKEN cDNA A730035I17 gene |
800 |
0.59 |
chr6_54563779_54563965 | 1.89 |
Scrn1 |
secernin 1 |
2617 |
0.25 |
chr10_34299043_34301066 | 1.89 |
Tspyl4 |
TSPY-like 4 |
798 |
0.4 |
chr13_56894338_56894545 | 1.87 |
Trpc7 |
transient receptor potential cation channel, subfamily C, member 7 |
1296 |
0.54 |
chr10_116017652_116019652 | 1.87 |
Ptprr |
protein tyrosine phosphatase, receptor type, R |
365 |
0.92 |
chr18_69675181_69675477 | 1.87 |
Tcf4 |
transcription factor 4 |
4370 |
0.34 |
chr2_121803809_121804141 | 1.87 |
Frmd5 |
FERM domain containing 5 |
2897 |
0.26 |
chr4_129440058_129441358 | 1.86 |
Zbtb8b |
zinc finger and BTB domain containing 8b |
110 |
0.94 |
chr9_41377643_41378358 | 1.84 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
1439 |
0.4 |
chr2_38341551_38341924 | 1.84 |
Lhx2 |
LIM homeobox protein 2 |
645 |
0.64 |
chr11_118906575_118907024 | 1.83 |
Rbfox3 |
RNA binding protein, fox-1 homolog (C. elegans) 3 |
1206 |
0.48 |
chr9_103760391_103760657 | 1.83 |
Tmem108 |
transmembrane protein 108 |
1266 |
0.55 |
chr13_44842150_44842855 | 1.83 |
Jarid2 |
jumonji, AT rich interactive domain 2 |
1719 |
0.39 |
chr9_74977325_74977617 | 1.82 |
Fam214a |
family with sequence similarity 214, member A |
1360 |
0.45 |
chr10_92404661_92405130 | 1.82 |
4930401A07Rik |
RIKEN cDNA 4930401A07 gene |
3881 |
0.24 |
chr10_111247804_111248910 | 1.81 |
Osbpl8 |
oxysterol binding protein-like 8 |
289 |
0.91 |
chr18_22345719_22346098 | 1.80 |
Asxl3 |
additional sex combs like 3, transcriptional regulator |
819 |
0.78 |
chrX_110816292_110817145 | 1.80 |
Pou3f4 |
POU domain, class 3, transcription factor 4 |
2438 |
0.34 |
chr2_65622311_65622547 | 1.77 |
Scn2a |
sodium channel, voltage-gated, type II, alpha |
1618 |
0.46 |
chr2_178141581_178143125 | 1.77 |
Phactr3 |
phosphatase and actin regulator 3 |
420 |
0.88 |
chr2_53501543_53502209 | 1.76 |
Gm13503 |
predicted gene 13503 |
50050 |
0.17 |
chr10_57788578_57789257 | 1.76 |
Fabp7 |
fatty acid binding protein 7, brain |
3994 |
0.2 |
chr12_71049290_71050137 | 1.75 |
Arid4a |
AT rich interactive domain 4A (RBP1-like) |
1372 |
0.4 |
chr9_75681964_75682559 | 1.75 |
Scg3 |
secretogranin III |
1326 |
0.37 |
chr13_55483242_55484428 | 1.74 |
Dbn1 |
drebrin 1 |
134 |
0.9 |
chr11_80479429_80480178 | 1.74 |
Cdk5r1 |
cyclin-dependent kinase 5, regulatory subunit 1 (p35) |
2747 |
0.26 |
chr15_25415436_25415919 | 1.72 |
Gm48957 |
predicted gene, 48957 |
614 |
0.58 |
chr15_88290858_88291278 | 1.72 |
B230214G05Rik |
RIKEN cDNA B230214G05 gene |
23806 |
0.21 |
chr3_80798726_80799058 | 1.72 |
Gria2 |
glutamate receptor, ionotropic, AMPA2 (alpha 2) |
3687 |
0.31 |
chr17_67699305_67699871 | 1.71 |
Lama1 |
laminin, alpha 1 |
2323 |
0.38 |
chr9_91378153_91379783 | 1.70 |
Zic4 |
zinc finger protein of the cerebellum 4 |
326 |
0.81 |
chr2_158606690_158608449 | 1.70 |
Gm14204 |
predicted gene 14204 |
3021 |
0.15 |
chr7_90386713_90387752 | 1.69 |
Sytl2 |
synaptotagmin-like 2 |
127 |
0.96 |
chr15_73021529_73022598 | 1.69 |
Trappc9 |
trafficking protein particle complex 9 |
33747 |
0.18 |
chr10_69020877_69021341 | 1.67 |
Gm33035 |
predicted gene, 33035 |
12779 |
0.23 |
chr3_73052207_73052615 | 1.66 |
Slitrk3 |
SLIT and NTRK-like family, member 3 |
4532 |
0.2 |
chr6_21217917_21219303 | 1.66 |
Kcnd2 |
potassium voltage-gated channel, Shal-related family, member 2 |
3107 |
0.33 |
chr11_54596874_54597434 | 1.65 |
Rapgef6 |
Rap guanine nucleotide exchange factor (GEF) 6 |
980 |
0.6 |
chr13_44841435_44841934 | 1.65 |
Jarid2 |
jumonji, AT rich interactive domain 2 |
901 |
0.61 |
chr6_32583482_32584367 | 1.65 |
Plxna4 |
plexin A4 |
4268 |
0.26 |
chr7_144175485_144176434 | 1.64 |
Shank2 |
SH3 and multiple ankyrin repeat domains 2 |
430 |
0.88 |
chr16_46008622_46009173 | 1.64 |
Plcxd2 |
phosphatidylinositol-specific phospholipase C, X domain containing 2 |
1321 |
0.41 |
chr3_144749493_144749850 | 1.64 |
Gm34866 |
predicted gene, 34866 |
189 |
0.91 |
chr5_110545888_110546039 | 1.64 |
Galnt9 |
polypeptide N-acetylgalactosaminyltransferase 9 |
1608 |
0.32 |
chr4_24848189_24848340 | 1.61 |
Klhl32 |
kelch-like 32 |
2667 |
0.31 |
chr6_101685397_101686121 | 1.61 |
Gm32453 |
predicted gene, 32453 |
33525 |
0.2 |
chr5_150260534_150260992 | 1.60 |
Fry |
FRY microtubule binding protein |
996 |
0.55 |
chr13_78191797_78192284 | 1.60 |
Nr2f1 |
nuclear receptor subfamily 2, group F, member 1 |
1597 |
0.28 |
chr10_21885462_21885797 | 1.58 |
Sgk1 |
serum/glucocorticoid regulated kinase 1 |
3260 |
0.23 |
chr5_102207711_102207963 | 1.57 |
Gm42933 |
predicted gene 42933 |
45546 |
0.15 |
chr14_65423052_65425451 | 1.56 |
Pnoc |
prepronociceptin |
909 |
0.6 |
chr12_74283886_74285221 | 1.56 |
1700086L19Rik |
RIKEN cDNA 1700086L19 gene |
264 |
0.9 |
chr18_43391464_43391742 | 1.55 |
Dpysl3 |
dihydropyrimidinase-like 3 |
1774 |
0.41 |
chrX_136290697_136291204 | 1.54 |
n-R5s12 |
nuclear encoded rRNA 5S 12 |
13445 |
0.09 |
chr9_56633518_56633669 | 1.53 |
Lingo1 |
leucine rich repeat and Ig domain containing 1 |
2035 |
0.33 |
chr8_12398370_12398923 | 1.53 |
Gm25239 |
predicted gene, 25239 |
2243 |
0.21 |
chr12_46814495_46815083 | 1.52 |
Nova1 |
NOVA alternative splicing regulator 1 |
2171 |
0.31 |
chr7_127874468_127874714 | 1.52 |
Zfp668 |
zinc finger protein 668 |
1055 |
0.23 |
chr14_48661734_48663217 | 1.52 |
Otx2 |
orthodenticle homeobox 2 |
397 |
0.71 |
chr6_97102606_97102759 | 1.52 |
Eogt |
EGF domain-specific O-linked N-acetylglucosamine (GlcNAc) transferase |
16072 |
0.17 |
chr14_105542543_105543399 | 1.50 |
Gm35909 |
predicted gene, 35909 |
24875 |
0.16 |
chrX_153141283_153141540 | 1.49 |
Rragb |
Ras-related GTP binding B |
1424 |
0.35 |
chrX_143667499_143667962 | 1.49 |
Pak3 |
p21 (RAC1) activated kinase 3 |
1985 |
0.47 |
chr8_34890130_34891317 | 1.48 |
Tnks |
tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase |
572 |
0.8 |
chrX_133682515_133683917 | 1.48 |
Pcdh19 |
protocadherin 19 |
1775 |
0.49 |
chr5_84413029_84413589 | 1.47 |
Epha5 |
Eph receptor A5 |
3497 |
0.31 |
chr19_6501834_6503156 | 1.47 |
Nrxn2 |
neurexin II |
4660 |
0.14 |
chr13_83724063_83724214 | 1.47 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
2757 |
0.18 |
chr17_25794599_25794750 | 1.46 |
Gm50367 |
predicted gene, 50367 |
985 |
0.18 |
chr7_137306984_137307575 | 1.46 |
Ebf3 |
early B cell factor 3 |
6637 |
0.2 |
chr15_98984593_98984775 | 1.46 |
4930578M01Rik |
RIKEN cDNA 4930578M01 gene |
1057 |
0.31 |
chr5_48598987_48600332 | 1.45 |
Kcnip4 |
Kv channel interacting protein 4 |
23 |
0.97 |
chr14_64592253_64592626 | 1.44 |
Mir3078 |
microRNA 3078 |
1254 |
0.34 |
chr15_85675690_85676550 | 1.44 |
Lncppara |
long noncoding RNA near Ppara |
22504 |
0.12 |
chr2_79452354_79452909 | 1.43 |
Neurod1 |
neurogenic differentiation 1 |
4120 |
0.24 |
chr7_64855942_64856628 | 1.43 |
Fam189a1 |
family with sequence similarity 189, member A1 |
112 |
0.97 |
chr8_108536302_108537095 | 1.42 |
Gm39244 |
predicted gene, 39244 |
249 |
0.95 |
chr2_6881042_6881689 | 1.42 |
Gm13389 |
predicted gene 13389 |
2905 |
0.24 |
chr1_42711455_42712692 | 1.42 |
Pantr2 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 2 |
1381 |
0.34 |
chr6_145047358_145048434 | 1.42 |
Bcat1 |
branched chain aminotransferase 1, cytosolic |
43 |
0.82 |
chr4_23602363_23602952 | 1.41 |
Gm25978 |
predicted gene, 25978 |
24088 |
0.22 |
chr18_43058416_43059778 | 1.40 |
Ppp2r2b |
protein phosphatase 2, regulatory subunit B, beta |
374 |
0.86 |
chr5_140724057_140724617 | 1.40 |
Amz1 |
archaelysin family metallopeptidase 1 |
199 |
0.93 |
chr13_84055030_84055254 | 1.39 |
Gm17750 |
predicted gene, 17750 |
9630 |
0.21 |
chr5_19746876_19747573 | 1.39 |
Magi2 |
membrane associated guanylate kinase, WW and PDZ domain containing 2 |
160294 |
0.04 |
chr13_116302578_116304501 | 1.39 |
Isl1 |
ISL1 transcription factor, LIM/homeodomain |
188 |
0.96 |
chr9_121777534_121778713 | 1.38 |
Gm47108 |
predicted gene, 47108 |
23 |
0.86 |
chr10_92161472_92161916 | 1.38 |
Rmst |
rhabdomyosarcoma 2 associated transcript (non-coding RNA) |
1067 |
0.55 |
chr1_175689767_175690985 | 1.38 |
Chml |
choroideremia-like |
2023 |
0.25 |
chr18_56287729_56288226 | 1.37 |
Gm50385 |
predicted gene, 50385 |
3125 |
0.3 |
chr8_23669147_23669298 | 1.37 |
Zmat4 |
zinc finger, matrin type 4 |
436 |
0.87 |
chr18_35212708_35213458 | 1.37 |
Ctnna1 |
catenin (cadherin associated protein), alpha 1 |
1847 |
0.28 |
chr2_4403551_4403975 | 1.36 |
Frmd4a |
FERM domain containing 4A |
2292 |
0.3 |
chr2_66041537_66041927 | 1.36 |
Galnt3 |
polypeptide N-acetylgalactosaminyltransferase 3 |
52339 |
0.12 |
chr3_34654574_34655689 | 1.36 |
Sox2ot |
SOX2 overlapping transcript (non-protein coding) |
905 |
0.42 |
chr3_17789318_17789657 | 1.35 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
434 |
0.83 |
chr10_78632111_78632432 | 1.35 |
Gm7842 |
predicted gene 7842 |
1971 |
0.16 |
chr1_77501424_77502014 | 1.35 |
Mir6352 |
microRNA 6352 |
4951 |
0.21 |
chr16_51521480_51521894 | 1.34 |
Gm49608 |
predicted gene, 49608 |
104739 |
0.08 |
chr1_32176002_32176211 | 1.34 |
Khdrbs2 |
KH domain containing, RNA binding, signal transduction associated 2 |
3219 |
0.33 |
chr18_82825279_82826286 | 1.34 |
4930445N18Rik |
RIKEN cDNA 4930445N18 gene |
30112 |
0.12 |
chr17_88094406_88094616 | 1.33 |
Fbxo11 |
F-box protein 11 |
29220 |
0.15 |
chr19_14593738_14594104 | 1.33 |
Tle4 |
transducin-like enhancer of split 4 |
1618 |
0.51 |
chr1_32174304_32174455 | 1.33 |
Khdrbs2 |
KH domain containing, RNA binding, signal transduction associated 2 |
1492 |
0.51 |
chr17_69438821_69440200 | 1.33 |
Akain1 |
A kinase (PRKA) anchor inhibitor 1 |
184 |
0.52 |
chr4_9269280_9270516 | 1.32 |
Clvs1 |
clavesin 1 |
551 |
0.81 |
chr11_34315414_34316667 | 1.32 |
Insyn2b |
inhibitory synaptic factor family member 2B |
1218 |
0.45 |
chr8_109250884_109251908 | 1.32 |
D030068K23Rik |
RIKEN cDNA D030068K23 gene |
1530 |
0.52 |
chr9_91382435_91383240 | 1.32 |
Zic4 |
zinc finger protein of the cerebellum 4 |
427 |
0.7 |
chr4_122998794_122999794 | 1.32 |
Mycl |
v-myc avian myelocytomatosis viral oncogene lung carcinoma derived |
45 |
0.97 |
chr10_57784547_57786586 | 1.31 |
Fabp7 |
fatty acid binding protein 7, brain |
643 |
0.68 |
chr18_83635209_83635363 | 1.31 |
Gm31621 |
predicted gene, 31621 |
2640 |
0.26 |
chr2_71525880_71527745 | 1.31 |
Dlx1as |
distal-less homeobox 1, antisense |
1107 |
0.33 |
chr15_37457581_37457955 | 1.30 |
Ncald |
neurocalcin delta |
773 |
0.56 |
chr2_52557337_52558561 | 1.30 |
Cacnb4 |
calcium channel, voltage-dependent, beta 4 subunit |
611 |
0.74 |
chr3_13946382_13947629 | 1.30 |
Ralyl |
RALY RNA binding protein-like |
594 |
0.84 |
chr17_90452047_90452824 | 1.29 |
Nrxn1 |
neurexin I |
2387 |
0.31 |
chr8_3585118_3585486 | 1.29 |
Rps23-ps2 |
ribosomal protein S23, pseudogene 2 |
1072 |
0.28 |
chr3_29957475_29957868 | 1.29 |
Gm37281 |
predicted gene, 37281 |
31135 |
0.15 |
chr14_76420544_76421824 | 1.28 |
Tsc22d1 |
TSC22 domain family, member 1 |
2356 |
0.39 |
chr7_36700078_36700692 | 1.28 |
Tshz3 |
teashirt zinc finger family member 3 |
2168 |
0.22 |
chr14_66864482_66864729 | 1.27 |
Dpysl2 |
dihydropyrimidinase-like 2 |
4083 |
0.18 |
chr6_114282516_114283979 | 1.27 |
Slc6a1 |
solute carrier family 6 (neurotransmitter transporter, GABA), member 1 |
457 |
0.87 |
chr6_8178385_8179063 | 1.27 |
Col28a1 |
collagen, type XXVIII, alpha 1 |
1450 |
0.43 |
chr8_34145118_34145536 | 1.27 |
Leprotl1 |
leptin receptor overlapping transcript-like 1 |
1706 |
0.21 |
chr8_92231343_92231684 | 1.27 |
Gm45334 |
predicted gene 45334 |
1612 |
0.42 |
chr3_45383889_45384379 | 1.26 |
Pcdh10 |
protocadherin 10 |
1501 |
0.35 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.1 | 6.4 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
0.9 | 2.7 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.7 | 2.2 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.6 | 1.9 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.6 | 2.5 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.6 | 1.9 | GO:0048880 | sensory system development(GO:0048880) |
0.6 | 1.1 | GO:0021986 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
0.5 | 1.6 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.5 | 2.0 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.5 | 1.4 | GO:0046552 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
0.5 | 1.4 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.4 | 1.7 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.4 | 1.2 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.4 | 2.5 | GO:0098596 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
0.4 | 1.6 | GO:0060594 | mammary gland specification(GO:0060594) |
0.4 | 2.8 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.4 | 2.4 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.4 | 1.1 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
0.4 | 3.9 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.4 | 1.4 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.4 | 2.1 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.4 | 1.1 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.4 | 1.4 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.3 | 2.4 | GO:0071625 | vocalization behavior(GO:0071625) |
0.3 | 0.6 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
0.3 | 1.8 | GO:0072017 | distal tubule development(GO:0072017) |
0.3 | 1.5 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.3 | 2.7 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
0.3 | 1.2 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
0.3 | 4.2 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.3 | 0.3 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
0.3 | 0.9 | GO:0021586 | pons maturation(GO:0021586) |
0.3 | 0.9 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.3 | 1.7 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.3 | 0.5 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.3 | 1.4 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.3 | 1.6 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
0.3 | 1.9 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.3 | 1.1 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.3 | 0.5 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.3 | 0.5 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.3 | 2.1 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.3 | 1.1 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.3 | 0.5 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
0.3 | 1.0 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.3 | 0.5 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.3 | 0.8 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.3 | 0.8 | GO:0032097 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.3 | 1.0 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.2 | 1.5 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.2 | 0.7 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.2 | 0.5 | GO:0035905 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
0.2 | 3.5 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.2 | 0.7 | GO:0002877 | regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) |
0.2 | 0.7 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.2 | 0.2 | GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
0.2 | 0.7 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.2 | 0.7 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.2 | 3.3 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.2 | 1.6 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.2 | 0.9 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.2 | 1.5 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.2 | 1.5 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.2 | 1.5 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.2 | 0.6 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.2 | 0.6 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.2 | 0.2 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
0.2 | 1.0 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.2 | 1.4 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.2 | 1.0 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.2 | 1.3 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.2 | 0.4 | GO:0043309 | regulation of eosinophil degranulation(GO:0043309) |
0.2 | 0.7 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.2 | 4.0 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.2 | 0.5 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.2 | 1.3 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.2 | 0.9 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
0.2 | 0.5 | GO:1901656 | glycoside transport(GO:1901656) |
0.2 | 0.5 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
0.2 | 0.7 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.2 | 0.5 | GO:0072194 | kidney smooth muscle tissue development(GO:0072194) |
0.2 | 1.5 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.2 | 0.6 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.2 | 1.1 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.2 | 0.5 | GO:0097503 | sialylation(GO:0097503) |
0.2 | 1.1 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.2 | 1.5 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.2 | 0.2 | GO:0097475 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.1 | 0.3 | GO:0097114 | NMDA glutamate receptor clustering(GO:0097114) |
0.1 | 0.9 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.1 | 1.3 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.1 | 0.3 | GO:0060174 | limb bud formation(GO:0060174) |
0.1 | 0.3 | GO:0060166 | olfactory pit development(GO:0060166) |
0.1 | 1.1 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.1 | 1.1 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.1 | 0.4 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
0.1 | 1.0 | GO:0097264 | self proteolysis(GO:0097264) |
0.1 | 0.7 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.1 | 0.4 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.1 | 0.5 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.1 | 0.3 | GO:2000040 | regulation of planar cell polarity pathway involved in axis elongation(GO:2000040) negative regulation of planar cell polarity pathway involved in axis elongation(GO:2000041) |
0.1 | 0.4 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.1 | 0.3 | GO:0061642 | chemoattraction of axon(GO:0061642) |
0.1 | 0.4 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.1 | 0.3 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.1 | 0.8 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.1 | 0.4 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.1 | 0.3 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.1 | 0.4 | GO:0015819 | lysine transport(GO:0015819) |
0.1 | 1.0 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.1 | 0.4 | GO:0072093 | ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
0.1 | 0.2 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.1 | 0.4 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.1 | 1.1 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.1 | 0.8 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.1 | 0.7 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.1 | 0.6 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.1 | 0.4 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.1 | 0.3 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
0.1 | 0.6 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.1 | 0.6 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.1 | 0.2 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.1 | 2.1 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.1 | 0.3 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.1 | 0.3 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
0.1 | 0.7 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.1 | 0.6 | GO:0030432 | peristalsis(GO:0030432) |
0.1 | 0.4 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 0.3 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.1 | 0.3 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.1 | 0.3 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.1 | 0.1 | GO:0086029 | Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
0.1 | 0.5 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.1 | 0.6 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.1 | 0.2 | GO:0031296 | B cell costimulation(GO:0031296) |
0.1 | 0.2 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.1 | 0.1 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.1 | 0.6 | GO:0016264 | gap junction assembly(GO:0016264) |
0.1 | 0.8 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.1 | 0.6 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.1 | 1.5 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.1 | 0.2 | GO:0071899 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
0.1 | 0.6 | GO:0050957 | equilibrioception(GO:0050957) |
0.1 | 0.3 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.1 | 1.7 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.1 | 0.3 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 0.3 | GO:0010288 | response to lead ion(GO:0010288) |
0.1 | 4.9 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.1 | 0.4 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.1 | 0.9 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.1 | 0.2 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
0.1 | 0.8 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.1 | 1.2 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.1 | 0.2 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.1 | 0.1 | GO:0021827 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) |
0.1 | 0.5 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.1 | 0.3 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.1 | 2.8 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.1 | 0.3 | GO:0046013 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.1 | 0.2 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.1 | 0.3 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.1 | 0.7 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.1 | 0.1 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.1 | 0.1 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.1 | 0.2 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.1 | 0.2 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.1 | 0.2 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.1 | 0.1 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.1 | 3.2 | GO:1900006 | positive regulation of dendrite development(GO:1900006) |
0.1 | 0.2 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.1 | 0.3 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.1 | 0.7 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.1 | 5.6 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.1 | 1.8 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.1 | 0.5 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.1 | 0.1 | GO:0070343 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
0.1 | 0.2 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.1 | 0.1 | GO:0060042 | retina morphogenesis in camera-type eye(GO:0060042) |
0.1 | 0.2 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
0.1 | 0.3 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.1 | 0.1 | GO:0090135 | actin filament branching(GO:0090135) |
0.1 | 0.1 | GO:0002125 | maternal aggressive behavior(GO:0002125) |
0.1 | 0.1 | GO:1901663 | quinone biosynthetic process(GO:1901663) |
0.1 | 1.9 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.1 | 0.1 | GO:1903935 | response to sodium arsenite(GO:1903935) |
0.1 | 0.3 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.1 | 0.2 | GO:0015755 | fructose transport(GO:0015755) |
0.1 | 0.2 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.1 | 0.1 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.1 | 0.3 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.1 | 0.1 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.1 | 0.5 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.1 | 0.5 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.1 | 0.3 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.1 | 0.1 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.1 | 0.7 | GO:0033089 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.1 | 0.1 | GO:0048664 | neuron fate determination(GO:0048664) |
0.1 | 0.5 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 0.5 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.1 | 0.1 | GO:1903802 | amino acid import into cell(GO:1902837) L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
0.1 | 0.6 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.1 | 0.1 | GO:0014900 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
0.1 | 0.2 | GO:0035627 | ceramide transport(GO:0035627) |
0.1 | 0.6 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.1 | 0.2 | GO:0032714 | negative regulation of interleukin-5 production(GO:0032714) |
0.1 | 0.1 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.1 | 0.4 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.1 | 0.1 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
0.1 | 0.2 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
0.1 | 0.2 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.1 | 0.2 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.1 | 0.4 | GO:0001964 | startle response(GO:0001964) |
0.1 | 0.6 | GO:1990403 | embryonic brain development(GO:1990403) |
0.1 | 0.2 | GO:0046909 | intermembrane transport(GO:0046909) |
0.1 | 0.1 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
0.1 | 0.4 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.1 | 0.1 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.1 | 0.3 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.1 | 0.2 | GO:0015888 | thiamine transport(GO:0015888) |
0.1 | 0.1 | GO:0071608 | macrophage inflammatory protein-1 alpha production(GO:0071608) |
0.1 | 0.1 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.1 | 0.1 | GO:0071280 | cellular response to copper ion(GO:0071280) |
0.1 | 0.2 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.0 | 0.1 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.0 | 0.1 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.0 | 0.0 | GO:0035973 | aggrephagy(GO:0035973) |
0.0 | 0.1 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.0 | 0.1 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.0 | 0.7 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.0 | 0.1 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.0 | 0.1 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.0 | 0.3 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.0 | 0.1 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.0 | 2.6 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.0 | 0.2 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.0 | 0.2 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.0 | 0.2 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.0 | 0.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 0.1 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.0 | 0.2 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.0 | 0.0 | GO:0021697 | cerebellar cortex formation(GO:0021697) |
0.0 | 0.3 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
0.0 | 0.2 | GO:0090383 | phagosome acidification(GO:0090383) |
0.0 | 0.1 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.0 | 0.1 | GO:0032375 | negative regulation of sterol transport(GO:0032372) negative regulation of cholesterol transport(GO:0032375) |
0.0 | 0.1 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.0 | 0.4 | GO:0007097 | nuclear migration(GO:0007097) |
0.0 | 1.1 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.0 | 0.1 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.0 | 0.3 | GO:0021694 | cerebellar Purkinje cell layer formation(GO:0021694) |
0.0 | 0.1 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.0 | 0.1 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.0 | 0.3 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.0 | 0.5 | GO:0006743 | ubiquinone metabolic process(GO:0006743) |
0.0 | 0.1 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.0 | 0.3 | GO:0014059 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.0 | 0.4 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.0 | 0.2 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.0 | 1.8 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.0 | 0.1 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.0 | 0.1 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.0 | 0.2 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.0 | 0.2 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.0 | 0.3 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.0 | 0.1 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.0 | 0.3 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.0 | 0.2 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.0 | 0.1 | GO:0061038 | uterus morphogenesis(GO:0061038) |
0.0 | 0.3 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.0 | 0.1 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.0 | 0.2 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.0 | 1.1 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.0 | 0.4 | GO:0036065 | fucosylation(GO:0036065) |
0.0 | 0.1 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.0 | 0.0 | GO:0014029 | neural crest formation(GO:0014029) |
0.0 | 0.1 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.0 | 0.1 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.0 | 0.0 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.0 | 0.1 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.0 | 0.3 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.0 | 0.1 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.0 | 0.1 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.0 | 0.2 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.0 | 0.0 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.0 | 0.1 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.0 | 0.1 | GO:0015747 | urate transport(GO:0015747) |
0.0 | 0.3 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.0 | 0.1 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.0 | 0.8 | GO:0006491 | N-glycan processing(GO:0006491) |
0.0 | 0.3 | GO:0042921 | glucocorticoid receptor signaling pathway(GO:0042921) |
0.0 | 1.0 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.0 | 0.1 | GO:0071675 | regulation of mononuclear cell migration(GO:0071675) positive regulation of mononuclear cell migration(GO:0071677) |
0.0 | 0.0 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.0 | 0.9 | GO:0021549 | cerebellum development(GO:0021549) |
0.0 | 0.2 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.0 | 0.0 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
0.0 | 0.1 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.0 | 0.1 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
0.0 | 0.3 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.0 | 0.1 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.0 | 0.0 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.0 | 0.1 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.0 | 0.4 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.0 | 0.1 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.0 | 0.0 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.0 | 0.1 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.0 | 0.1 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.0 | 0.1 | GO:0042891 | antibiotic transport(GO:0042891) |
0.0 | 0.2 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
0.0 | 0.1 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.0 | 0.1 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.0 | 0.1 | GO:0009169 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.0 | 0.4 | GO:0007141 | male meiosis I(GO:0007141) |
0.0 | 0.1 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.0 | 0.0 | GO:0043133 | hindgut contraction(GO:0043133) regulation of hindgut contraction(GO:0043134) |
0.0 | 0.2 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.0 | 0.0 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.0 | 0.2 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.0 | 0.1 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.0 | 0.0 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.0 | 0.1 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.0 | 0.3 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.0 | 0.0 | GO:2000002 | negative regulation of DNA damage checkpoint(GO:2000002) |
0.0 | 0.1 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.0 | 0.1 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.0 | 0.1 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.0 | 0.2 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.0 | 0.1 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.0 | 0.1 | GO:0060029 | convergent extension involved in organogenesis(GO:0060029) |
0.0 | 0.1 | GO:0034447 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) very-low-density lipoprotein particle clearance(GO:0034447) |
0.0 | 0.2 | GO:0071731 | response to nitric oxide(GO:0071731) |
0.0 | 0.1 | GO:0001546 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
0.0 | 0.3 | GO:0021879 | forebrain neuron differentiation(GO:0021879) |
0.0 | 0.2 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.0 | 0.1 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.0 | 0.2 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.0 | 0.1 | GO:0014028 | notochord formation(GO:0014028) |
0.0 | 0.1 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.0 | 0.1 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.0 | 0.1 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.0 | 0.1 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.0 | 0.0 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.0 | 0.0 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.0 | 0.1 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.0 | 1.4 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.0 | 0.0 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.0 | 0.0 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.0 | 0.0 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.0 | 0.0 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.0 | 0.3 | GO:0015800 | acidic amino acid transport(GO:0015800) |
0.0 | 0.1 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.0 | 0.1 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.0 | 0.1 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.1 | GO:0032429 | regulation of phospholipase A2 activity(GO:0032429) |
0.0 | 0.1 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.0 | 0.3 | GO:0006828 | manganese ion transport(GO:0006828) |
0.0 | 0.2 | GO:2000269 | regulation of fibroblast apoptotic process(GO:2000269) |
0.0 | 0.1 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.0 | 0.0 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.0 | 0.0 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.0 | 0.0 | GO:0070268 | cornification(GO:0070268) |
0.0 | 0.1 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.0 | 0.1 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.0 | 0.1 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.0 | 0.0 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
0.0 | 0.1 | GO:1902268 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) negative regulation of polyamine transmembrane transport(GO:1902268) |
0.0 | 0.1 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.0 | 0.1 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.0 | 0.1 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.0 | 0.1 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.0 | 0.0 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.0 | 0.1 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.0 | 0.2 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.0 | 0.0 | GO:1904180 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.0 | 0.1 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.0 | 0.0 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
0.0 | 0.1 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.0 | 0.1 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.0 | 0.1 | GO:0006477 | protein sulfation(GO:0006477) |
0.0 | 0.1 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.0 | 0.1 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.0 | 0.0 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.0 | 0.7 | GO:0003407 | neural retina development(GO:0003407) |
0.0 | 0.1 | GO:0001555 | oocyte growth(GO:0001555) |
0.0 | 0.0 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.0 | 0.2 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.0 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) |
0.0 | 0.1 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.0 | 0.1 | GO:0006116 | NADH oxidation(GO:0006116) |
0.0 | 0.1 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.0 | 0.1 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.0 | 0.2 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.0 | 0.0 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.0 | 0.1 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.0 | 0.1 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.0 | 0.1 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.0 | 0.0 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.0 | 0.5 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.0 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.0 | 0.0 | GO:0040023 | establishment of nucleus localization(GO:0040023) |
0.0 | 0.1 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.0 | 0.0 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.0 | 1.1 | GO:0014065 | phosphatidylinositol 3-kinase signaling(GO:0014065) |
0.0 | 0.1 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.0 | 0.1 | GO:0019471 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) |
0.0 | 0.0 | GO:0097466 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.0 | 0.1 | GO:0060717 | chorion development(GO:0060717) extraembryonic membrane development(GO:1903867) |
0.0 | 0.2 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.0 | 0.2 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 0.1 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.0 | 0.0 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.0 | 0.3 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.0 | 0.1 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.0 | 0.1 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
0.0 | 0.1 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.0 | 0.1 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.0 | 0.0 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
0.0 | 0.0 | GO:0070572 | positive regulation of neuron projection regeneration(GO:0070572) |
0.0 | 0.3 | GO:0060612 | adipose tissue development(GO:0060612) |
0.0 | 0.1 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.0 | 0.0 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.0 | 0.1 | GO:0002016 | regulation of blood volume by renin-angiotensin(GO:0002016) brain renin-angiotensin system(GO:0002035) |
0.0 | 0.1 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.0 | 0.1 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.0 | 0.2 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
0.0 | 0.1 | GO:0010666 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.0 | 0.1 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.0 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.0 | 0.0 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.0 | 0.0 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.0 | 0.0 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.0 | 0.2 | GO:0007616 | long-term memory(GO:0007616) |
0.0 | 0.1 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.0 | 0.3 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.0 | 0.1 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.0 | 0.0 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.0 | 0.2 | GO:0030033 | microvillus assembly(GO:0030033) |
0.0 | 0.0 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.0 | 0.1 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.0 | 0.1 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
0.0 | 0.1 | GO:0051194 | positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
0.0 | 0.0 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.0 | 0.0 | GO:0032530 | regulation of microvillus organization(GO:0032530) |
0.0 | 0.1 | GO:0016322 | neuron remodeling(GO:0016322) |
0.0 | 0.1 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.0 | 0.0 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.0 | 0.0 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
0.0 | 0.2 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.0 | 0.1 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.0 | 0.0 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.0 | 0.1 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
0.0 | 0.2 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.0 | 0.0 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.0 | 0.0 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.0 | 0.0 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.0 | 0.1 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.0 | 0.3 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.0 | 0.2 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.0 | 0.3 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.0 | 0.0 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.0 | 0.1 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.0 | 0.1 | GO:1902692 | regulation of neuroblast proliferation(GO:1902692) |
0.0 | 0.0 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.0 | 0.2 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.0 | 0.1 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.0 | 0.0 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.0 | 0.1 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.0 | 0.0 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.0 | 0.0 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.0 | 0.1 | GO:1903624 | regulation of DNA catabolic process(GO:1903624) |
0.0 | 0.2 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.0 | 0.1 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.0 | 0.0 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.0 | 0.1 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.0 | 0.0 | GO:0097576 | vacuole fusion(GO:0097576) |
0.0 | 0.1 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.0 | 0.0 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.0 | 0.0 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.0 | 0.0 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.0 | 0.0 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.0 | 0.0 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.0 | 0.0 | GO:0032079 | positive regulation of endodeoxyribonuclease activity(GO:0032079) |
0.0 | 0.0 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.0 | 0.1 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.0 | 0.2 | GO:0016079 | synaptic vesicle exocytosis(GO:0016079) |
0.0 | 0.0 | GO:0043931 | ossification involved in bone maturation(GO:0043931) |
0.0 | 0.0 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
0.0 | 0.0 | GO:0048840 | otolith development(GO:0048840) |
0.0 | 0.0 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.0 | 0.0 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.0 | 0.0 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.0 | 0.0 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.0 | 0.0 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.0 | 0.0 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.0 | 0.0 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
0.0 | 0.1 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.0 | 0.1 | GO:0051642 | centrosome localization(GO:0051642) |
0.0 | 0.1 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.0 | 0.0 | GO:0071649 | regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) |
0.0 | 0.1 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
0.0 | 0.0 | GO:1904970 | brush border assembly(GO:1904970) |
0.0 | 0.0 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 4.2 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.5 | 3.9 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.4 | 1.6 | GO:0044308 | axonal spine(GO:0044308) |
0.3 | 1.3 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.2 | 1.0 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.2 | 0.2 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.2 | 1.6 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.2 | 0.7 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.2 | 0.7 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.2 | 0.2 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.2 | 0.4 | GO:0097441 | basilar dendrite(GO:0097441) |
0.2 | 0.6 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.2 | 11.5 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.2 | 1.3 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.2 | 1.3 | GO:0032584 | growth cone membrane(GO:0032584) |
0.2 | 0.7 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.2 | 2.1 | GO:0030673 | axolemma(GO:0030673) |
0.2 | 1.5 | GO:0005883 | neurofilament(GO:0005883) |
0.2 | 1.4 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.2 | 1.9 | GO:0043194 | axon initial segment(GO:0043194) |
0.2 | 0.9 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.1 | 0.4 | GO:0000322 | storage vacuole(GO:0000322) |
0.1 | 1.3 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.1 | 0.5 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.1 | 2.3 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.1 | 1.6 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.1 | 0.9 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.1 | 2.5 | GO:0044295 | axonal growth cone(GO:0044295) |
0.1 | 10.6 | GO:0030427 | site of polarized growth(GO:0030427) |
0.1 | 1.2 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.1 | 0.1 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
0.1 | 0.5 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.1 | 0.5 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.1 | 0.3 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.1 | 1.3 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 0.7 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 12.3 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.1 | 0.5 | GO:0044292 | dendrite terminus(GO:0044292) |
0.1 | 0.2 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.1 | 0.5 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 0.7 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 0.4 | GO:0043083 | synaptic cleft(GO:0043083) |
0.1 | 0.6 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 1.3 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.1 | 0.5 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 1.0 | GO:0043205 | fibril(GO:0043205) |
0.1 | 0.2 | GO:0034706 | sodium channel complex(GO:0034706) |
0.1 | 0.3 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 0.1 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.1 | 1.7 | GO:0043198 | dendritic shaft(GO:0043198) |
0.1 | 0.6 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 0.8 | GO:0032590 | dendrite membrane(GO:0032590) |
0.1 | 1.8 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.1 | 0.8 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.1 | 0.5 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 0.2 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.0 | 0.2 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.0 | 0.1 | GO:0031417 | NatC complex(GO:0031417) |
0.0 | 1.3 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.0 | 0.5 | GO:0031045 | dense core granule(GO:0031045) |
0.0 | 0.9 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.0 | 0.3 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.0 | 0.2 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 0.3 | GO:0097386 | glial cell projection(GO:0097386) |
0.0 | 0.1 | GO:0005638 | lamin filament(GO:0005638) |
0.0 | 0.2 | GO:0016600 | flotillin complex(GO:0016600) |
0.0 | 0.1 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.0 | 0.1 | GO:0035363 | histone locus body(GO:0035363) |
0.0 | 0.2 | GO:0016589 | NURF complex(GO:0016589) |
0.0 | 0.2 | GO:0001940 | male pronucleus(GO:0001940) |
0.0 | 0.0 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.0 | 0.2 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.0 | 0.1 | GO:1990423 | RZZ complex(GO:1990423) |
0.0 | 4.3 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.1 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.0 | 0.3 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.0 | 0.4 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.0 | 0.3 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.0 | 0.0 | GO:0044393 | microspike(GO:0044393) |
0.0 | 0.9 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 1.8 | GO:0005643 | nuclear pore(GO:0005643) |
0.0 | 0.5 | GO:0030904 | retromer complex(GO:0030904) |
0.0 | 0.5 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.0 | 0.1 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.0 | 0.5 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 0.3 | GO:0035102 | PRC1 complex(GO:0035102) |
0.0 | 0.1 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.0 | 2.2 | GO:0043679 | axon terminus(GO:0043679) |
0.0 | 0.2 | GO:0045120 | pronucleus(GO:0045120) |
0.0 | 0.1 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.0 | 1.1 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.0 | 0.1 | GO:0000802 | transverse filament(GO:0000802) |
0.0 | 0.1 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.0 | 0.3 | GO:0031011 | Ino80 complex(GO:0031011) |
0.0 | 0.0 | GO:0032280 | symmetric synapse(GO:0032280) |
0.0 | 0.1 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.0 | 1.0 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.0 | 0.1 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.0 | 0.1 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.0 | 1.2 | GO:0043204 | perikaryon(GO:0043204) |
0.0 | 0.5 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 0.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.0 | 0.1 | GO:0070552 | BRISC complex(GO:0070552) |
0.0 | 0.6 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.2 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.0 | 0.1 | GO:0043203 | axon hillock(GO:0043203) |
0.0 | 0.2 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.0 | 1.2 | GO:0016363 | nuclear matrix(GO:0016363) |
0.0 | 0.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 0.1 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.0 | 0.1 | GO:0005745 | m-AAA complex(GO:0005745) |
0.0 | 1.1 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.0 | 0.1 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.0 | 0.7 | GO:0032587 | ruffle membrane(GO:0032587) |
0.0 | 0.1 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.0 | 0.0 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.0 | 0.1 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.0 | 0.2 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 0.2 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 0.0 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.0 | 0.4 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.0 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.0 | 0.2 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.0 | 0.5 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 0.1 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.0 | 0.1 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.0 | 0.1 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.0 | 0.1 | GO:0098536 | deuterosome(GO:0098536) |
0.0 | 0.1 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.0 | 0.0 | GO:0032437 | cuticular plate(GO:0032437) |
0.0 | 0.1 | GO:0000974 | Prp19 complex(GO:0000974) |
0.0 | 0.1 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
0.0 | 0.2 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 4.8 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
1.1 | 2.2 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.7 | 2.2 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.5 | 1.6 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.5 | 1.4 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.4 | 1.5 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.4 | 0.4 | GO:0051378 | serotonin binding(GO:0051378) |
0.3 | 1.0 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.3 | 2.2 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.3 | 1.2 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.3 | 1.5 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.3 | 0.9 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.3 | 0.9 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.3 | 0.9 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.3 | 0.3 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.3 | 1.9 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.3 | 1.4 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.3 | 0.8 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.2 | 0.7 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.2 | 2.6 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.2 | 1.3 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.2 | 0.7 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.2 | 4.2 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.2 | 1.7 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.2 | 1.8 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.2 | 1.0 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.2 | 2.6 | GO:0031005 | filamin binding(GO:0031005) |
0.2 | 1.9 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.2 | 0.7 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.2 | 0.4 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.2 | 1.6 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.2 | 0.5 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.2 | 0.7 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.2 | 0.8 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.2 | 2.8 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.2 | 0.2 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.2 | 1.3 | GO:0008430 | selenium binding(GO:0008430) |
0.1 | 3.7 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 3.2 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 1.6 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 1.3 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 0.5 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.1 | 0.5 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.1 | 0.4 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.1 | 2.2 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 0.5 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 2.8 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 1.3 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 0.6 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.1 | 3.9 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.1 | 1.5 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.1 | 0.8 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 0.2 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.1 | 2.0 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 0.2 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.1 | 0.5 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 0.5 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.1 | 0.9 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.1 | 0.2 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.1 | 0.6 | GO:0003680 | AT DNA binding(GO:0003680) |
0.1 | 0.3 | GO:0097016 | L27 domain binding(GO:0097016) |
0.1 | 1.7 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.1 | 0.6 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.1 | 1.2 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.1 | 0.6 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.1 | 1.0 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 0.7 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 0.6 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.1 | 1.0 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.1 | 2.1 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.1 | 0.3 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.1 | 0.4 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.1 | 0.3 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.1 | 0.9 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 0.3 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.1 | 1.2 | GO:0031402 | sodium ion binding(GO:0031402) |
0.1 | 0.6 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 2.2 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.1 | 0.2 | GO:0097001 | ceramide binding(GO:0097001) |
0.1 | 1.4 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 0.3 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 2.0 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.1 | 0.5 | GO:0034791 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.1 | 0.7 | GO:0016594 | glycine binding(GO:0016594) |
0.1 | 0.2 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.1 | 0.2 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.1 | 1.6 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 0.2 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.1 | 1.8 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 0.3 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 0.1 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.1 | 1.2 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 0.4 | GO:0036122 | BMP binding(GO:0036122) |
0.1 | 0.3 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.1 | 0.3 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.1 | 0.6 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.1 | 0.1 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.1 | 0.2 | GO:0019808 | polyamine binding(GO:0019808) |
0.1 | 0.3 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 0.8 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.1 | 0.9 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 0.3 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.1 | 0.5 | GO:0048156 | tau protein binding(GO:0048156) |
0.0 | 0.2 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.0 | 0.2 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.0 | 0.2 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.0 | 0.1 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.0 | 0.2 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.0 | 0.1 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.0 | 0.2 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.0 | 0.2 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.0 | 0.4 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.0 | 0.1 | GO:0045340 | mercury ion binding(GO:0045340) |
0.0 | 0.2 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.0 | 0.8 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.1 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.0 | 0.4 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.0 | 0.1 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.0 | 0.2 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.0 | 0.3 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.0 | 0.0 | GO:0032356 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.0 | 0.2 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 0.2 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.4 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.0 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.0 | 0.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.0 | 0.1 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 0.3 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.0 | 0.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.0 | 0.8 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.0 | 0.1 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.0 | 0.4 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.0 | 0.1 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.0 | 0.1 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
0.0 | 0.2 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.0 | 0.1 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) cardiolipin binding(GO:1901612) |
0.0 | 0.1 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.0 | 0.5 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.2 | GO:0048495 | Roundabout binding(GO:0048495) |
0.0 | 0.9 | GO:0008483 | transaminase activity(GO:0008483) |
0.0 | 0.5 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.0 | 0.1 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.0 | 0.1 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.0 | 0.2 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.0 | 0.2 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.0 | 0.4 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 2.3 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 0.3 | GO:0043495 | protein anchor(GO:0043495) |
0.0 | 0.2 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.0 | 0.5 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.2 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.0 | 0.1 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.0 | 0.9 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.0 | 0.0 | GO:0015172 | acidic amino acid transmembrane transporter activity(GO:0015172) |
0.0 | 0.6 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.0 | 0.7 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.0 | 1.1 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.0 | 0.1 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.0 | 0.2 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.0 | 0.2 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.0 | 0.2 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.0 | 0.3 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.0 | 0.1 | GO:0030911 | TPR domain binding(GO:0030911) |
0.0 | 0.8 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.0 | 0.1 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.0 | 0.4 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.0 | 0.2 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.0 | 0.1 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.0 | 0.1 | GO:0034452 | dynactin binding(GO:0034452) |
0.0 | 0.4 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 0.3 | GO:0070402 | NADPH binding(GO:0070402) |
0.0 | 0.4 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.0 | 0.1 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.0 | 0.1 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.0 | 0.1 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.0 | 0.2 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.0 | 0.3 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.0 | 0.2 | GO:0005113 | patched binding(GO:0005113) |
0.0 | 0.1 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.0 | 0.1 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.0 | 0.1 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.0 | 0.1 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.0 | 0.1 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.0 | 0.0 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.0 | 0.2 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.0 | 0.1 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.0 | 0.1 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.0 | 0.2 | GO:0004568 | chitinase activity(GO:0004568) |
0.0 | 0.1 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.0 | 0.1 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.0 | 0.6 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.4 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.0 | 0.1 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.0 | 0.1 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.0 | 0.0 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.0 | 0.0 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.0 | 0.0 | GO:1990188 | euchromatin binding(GO:1990188) |
0.0 | 0.3 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.0 | 0.6 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.0 | 0.1 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.0 | 0.0 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.0 | 0.1 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.0 | 0.1 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.0 | 0.0 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.0 | 0.2 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.0 | 0.1 | GO:1990405 | protein antigen binding(GO:1990405) |
0.0 | 0.0 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.0 | 0.1 | GO:0016936 | galactoside binding(GO:0016936) |
0.0 | 0.0 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
0.0 | 0.1 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.4 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 2.7 | GO:0003729 | mRNA binding(GO:0003729) |
0.0 | 0.0 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.0 | 0.1 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.0 | 0.1 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.0 | 0.0 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.0 | 0.1 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.0 | 0.1 | GO:0035197 | siRNA binding(GO:0035197) |
0.0 | 0.1 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.0 | 0.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.2 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.0 | 0.1 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.0 | 0.1 | GO:0052758 | 4-methyloctanoyl-CoA dehydrogenase activity(GO:0034580) naphthyl-2-methyl-succinyl-CoA dehydrogenase activity(GO:0034845) 2-methylhexanoyl-CoA dehydrogenase activity(GO:0034916) propionyl-CoA dehydrogenase activity(GO:0043820) thiol-driven fumarate reductase activity(GO:0043830) coenzyme F420-dependent 2,4,6-trinitrophenol reductase activity(GO:0052758) coenzyme F420-dependent 2,4,6-trinitrophenol hydride reductase activity(GO:0052759) coenzyme F420-dependent 2,4-dinitrophenol reductase activity(GO:0052760) |
0.0 | 0.4 | GO:0045296 | cadherin binding(GO:0045296) |
0.0 | 0.1 | GO:0031420 | alkali metal ion binding(GO:0031420) |
0.0 | 0.8 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.1 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.0 | 0.0 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.0 | 0.1 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.0 | 0.3 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.0 | 0.0 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.0 | 0.1 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.1 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.0 | 0.0 | GO:0034929 | fluorene oxygenase activity(GO:0018585) mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.0 | 0.1 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.0 | 0.5 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.0 | 0.1 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.0 | 0.1 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.0 | 0.0 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.0 | 0.1 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.0 | 0.1 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.0 | 0.7 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.1 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.0 | 0.1 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.0 | 0.0 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.0 | 0.1 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.0 | 0.0 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.0 | 0.1 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.0 | 0.0 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.0 | 0.0 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.0 | 0.0 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.0 | 0.1 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.0 | 0.0 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.0 | 0.0 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.0 | 0.0 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.0 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.0 | 0.1 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.0 | GO:0090079 | translation regulator activity, nucleic acid binding(GO:0090079) |
0.0 | 0.1 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.0 | 0.1 | GO:0015026 | coreceptor activity(GO:0015026) |
0.0 | 0.0 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.0 | 0.1 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.0 | 0.0 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.0 | 0.2 | GO:0031489 | myosin V binding(GO:0031489) |
0.0 | 0.1 | GO:0033558 | histone deacetylase activity(GO:0004407) protein deacetylase activity(GO:0033558) |
0.0 | 0.0 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 2.4 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 0.5 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 2.7 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 1.9 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 1.5 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 3.9 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 1.5 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 0.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 1.3 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.1 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 1.2 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.4 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 0.0 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 0.2 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 0.5 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.4 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.8 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.6 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.0 | 0.4 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 0.0 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 0.0 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 0.2 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.9 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 0.4 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.4 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.1 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.3 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.4 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.3 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.3 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.4 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.8 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.1 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.1 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 0.1 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 0.0 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 0.4 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.3 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 0.2 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 0.1 | ST STAT3 PATHWAY | STAT3 Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 4.4 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.3 | 4.6 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.2 | 0.2 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.2 | 3.4 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.2 | 1.7 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.2 | 1.7 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.1 | 2.1 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.1 | 2.7 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 0.4 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.1 | 1.5 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.1 | 3.2 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 2.4 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.1 | 1.3 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 1.0 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.1 | 0.3 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.1 | 1.4 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.1 | 2.0 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 0.1 | REACTOME OPIOID SIGNALLING | Genes involved in Opioid Signalling |
0.1 | 1.9 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.1 | 0.1 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.1 | 2.5 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 1.3 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.1 | 0.3 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 0.8 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 0.7 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 1.1 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 0.3 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.1 | 1.0 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 0.8 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.1 | 1.0 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 0.3 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 0.6 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.0 | 0.9 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.3 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.0 | 0.4 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.0 | 0.2 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.8 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 0.5 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 1.5 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.0 | 0.3 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.0 | 0.6 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 0.5 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.0 | 0.6 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 0.1 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.0 | 0.4 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 0.4 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 0.7 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 0.2 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.0 | 0.0 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 0.0 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.0 | 0.3 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.2 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 0.2 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.2 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 0.1 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.0 | 0.2 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.0 | 0.6 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.0 | 0.1 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.0 | 0.1 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 0.2 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.0 | 2.7 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.1 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.0 | 0.1 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.0 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.0 | 0.2 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.5 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.5 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 0.0 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.0 | 0.0 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.0 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.0 | 0.2 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 0.1 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.0 | 0.5 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |